Fig. 2From: Patients with metastatic renal cell carcinoma who benefit from axitinib dose titration: analysis from a randomised, double-blind phase II studyStudy design [8]. Abbreviations: bid twice daily; BP blood pressure; HTN hypertensionBack to article page